Access cutting-edge covid-19 treatment through this clinical trial at a research site in Anniston. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Anniston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19). In order to represent a more recently circulating SARS-CoV-2 variant, the main study endpoints will now evaluate the VXA-CoV2-3.3 (KP.2 strain) vaccine, and not the VXA-CoV2-3.1 (XBB.1.5 strain)
Sponsor: Vaxart
Check if you qualify for this covid-19 clinical trial in Anniston, AL
If you're searching for covid-19 treatment options in Anniston, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anniston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.